Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: | Evrysdi |
Active Ingredient: | Risdiplam 0.75mg/mL |
Dosage Form: | Powder for oral solution |
New Zealand Sponsor: | Roche Products (NZ) Limited |
Manufacturer: | F Hoffmann-La Roche Limited, Basel, Switzerland |
Product: | Optifix |
Active Ingredient: | Naphazoline hydrochloride 0.1%w/v |
Dosage Form: | Eye drops, solution |
New Zealand Sponsor: | Pharmabroker Sales Limited |
Manufacturer: | Bruschettini S.R.L., Genova, Italy |
Product: | Scholl Clotrimazole Athlete’s Foot Cream |
Active Ingredient: | Clotrimazole 10mg/g |
Dosage Form: | Topical cream |
New Zealand Sponsor: | Reckitt Benckiser (New Zealand) Limited |
Manufacturer: | PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand |
Product: | Ticagrelor Sandoz |
Active Ingredient: | Ticagrelor 60mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Novartis New Zealand Limited |
Manufacturer: | PharOS MT Limited, Birzebbugia, Malta |
Product: | Ticagrelor Sandoz |
Active Ingredient: | Ticagrelor 90mg |
Dosage Form: | Film coated tablet |
New Zealand Sponsor: | Novartis New Zealand Limited |
Manufacturer: | PharOS MT Limited, Birzebbugia, Malta |
Dated this 20th day of January 2022.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).